Tag: Cannabis Science Inc (OTCMKTS:CBIS)

Cannabis Science Inc. (OTCMKTS:CBIS) has announced that their RCD will begin to use www.iCannabinoid.com platform for information sharing as well as interaction with the general public on the company’s on-going projects, partnership programs, drug development initiatives, university scholarship programs, CBIS consortium as well as all their other RCD initiatives.

iCannabinoid prompted by shareholder response

Following the extension of the registration date for the Personal Shareholder Loyalty Gift through to the end of January, the company received an overwhelming response. During the period the company has indicated that they received everything and compiling and tracking of information until they responded improved.

Because of the large number of questions and registrations that the company received on the matter and other inquiries the company has considered having an interactive online platform and instead of choosing the mainstream interaction sites they chose www.iCannabinoid.com platform that launched recently.

Cannabis Science CEO and Co-founder, Raymond Dabney, stated that they are seeing people starting to get it of what the company stands for and the numerous positive changes that they have made on the University economic drug development programs. He said that new partnerships have extraordinarily risen as well as investment inquiries. The CEO added that the company’s growth potential is fantastic and they are looking to create jobs in almost every industry across the board.

iCannabinoid enhancing interaction

According to the company they expect the platform to help in bringing it all together as well as streamline the communications with doctors, patients, journalists, government, growers as well as private sector and any interested party. The company has directed that all loyalty gift questions, as well as company activities and initiatives, should be relayed through the iCannabinoid platform.

The CEO indicated that the platform is the perfect avenue of bringing it all together to have enhanced interactive communication and it will enable the company to engage the community actively on a range of issues that are relevant in the industry. For Shareholder Loyalty Gifts application the company will process applications and reconcile with previous requests, and they will invite gift recipients to the Cannabis Science Black-tie Awards Gala.

The past year has been quite trying for Cannabis Science Inc (OTCMKTS:CBIS) in terms of business operations which has adversely impacted on its financial results. During that period, the company experienced operations disruptions occasioned by the seizure of the 26.19-acre plot of land by Federal Authorities. The land contained industrial hemp that was being grown for production and sale to the market.

However, in a July press release, the company announced the signing of another “substantial” land deal for 100 acres in Minden, Nevada. According to the company, the new acquisition falls directly in line with the rest of the certified industrial hemp research and development projects across North America.

 Industrial Hemp Research & Economic Development Plan

Per the release, the company will continue to work in league with its multiple worldwide partners through the CBIS Consortium to focus on the major ailments inflicting humanity. The report reveals that the research data collected will primarily be used by FDA and other clinical studies.

The release lays bare the fact that the research initiative is also geared at providing hands-on University professional training in agricultural industrial hemp research and development. The report also mentioned that the research is aimed at creating jobs through the participating Universities, a move which will positively impact the economy of the region.

A raft of measures aimed at restructuring

Another press release, August 13, notes that the objectives aforementioned cannot be achieved without a number of measures that the company is putting in place. The release details that the company is in the final process of releasing its new corporate website as well as introducing a freshly constituted management.

As per the release, the new measures will be crucial in the company’s efforts to conduct key acquisitions, multiple dispensary openings, the new important research opportunities aforementioned, new partnerships, operation expansions and also in implementing the updated financial reporting requirements.

The release also details that due to a number of staff that exited in the past year, the company intends to onboard new people who will come in to help steer the company’s strategy.

Cannabis Science Inc (OTCMKTS:CBIS) reported that company has entered into the multi-billion USD beverage market as it associates with Crown Baus Capital to supply non-alcohol versions of latter’s newly bought “Cannabia(R)”.

The buzz

Raymond C. Dabney, the Co-Founder, CEO and President of Cannabis Science, expressed that with company stepping in to help grow the Brand expansions, the deal of Cannabia(R) is strategically vital to the growth plan of Crown Baus, Cannabis Science and their associates. With more deals planned they will complement their operational growth and enhance profitability so savings can be moved on to their general-public customers and self-medicating patients.

Sales of Cannabia® have been increasing 15% to 25% per year; it is anticipated to see beverage sales to grow considerably as Cannabis Science is set to launch Cannabia(R) products into the Canadian and United States markets to begin. California alone is the sixth-largest economy across the world with a GDP of as much as $2.5 trillion. This instantly exhibits an extremely lucrative market opportunity for both of their firms with Cannabis Science set to release existing and new Cannabia(R) product brands with television media campaigns in the U.S. and Canada.

As per the update, Cannabia’s(R) first hemp drink, a cannabis beer, was introduced in March 1996 when Germany formally authorized the hemp cultivation, the so-named “fiber hemp”. A secret, hand-chosen combination of organic barley malt, hemp and hops provide Cannabia(R) its unmistakable hemp aroma and rich taste.

Cannabia(R) is currently supplied in numerous European Union nations, as well as in several vital markets, including Japan, Switzerland, India and South Korea. Distribution of Cannabia(R) is anticipated to expand fast to new markets with new supplier inquires. Cannabis Science reported that Cannabia(R) is prepared in Germany partly as a traditional organic “Pils” and in next step, a secret select organic hemp.

Cannabis Science Inc (OTCMKTS:CBIS) reported that its expansion plans for company’s medical marijuana dispensaries are on track. The firm has recently finalized deals to buy and officially launch the first two company PRE ICO Medical Marijuana dispensaries in the greater San Fernando Valley and in Los Angeles. Both dispensaries are planned to start at the end of this year to fulfill the anticipated demand in the Los Angeles area from the much sought California recreational market influx in the coming month.

The details

Raymond C. Dabney, the CEO, Co-Founder and President of Cannabis Science, reported that starting the first two PRE ICO Dispensaries by the close of this year is a remarkable step for company and accelerates their aggressive expansion strategies in the Los Angeles area, expanding to California, and eventually countrywide.

They project to start numerous compliant PRE ICO dispensary sites throughout California via several means. Their timing couldn’t be better as Los Angeles just approved its recreational marijuana use guidelines for the starting of January 2018. They are strategically positioned to fulfill the demands of new clients in the recreational and medical cannabis markets with a substantial supply of their CBIS offerings addressing the around 700 medical applications of cannabis.

With New Year right around the corner, Cannabis Science has opted to focus on starting these two sites by the close of this year. Dabney added that the opportunity came late last quarter and they ensured they were there to answer. The company first wants to open the two locations and then plan for the Gala event for celebration of achievements.

The opening and acquisition of these Medical Marijuana dispensaries is a remarkable step in Cannabis Science 2017 development plan and is anticipated to help the firm achieve revenue-positive status in imminent year. Cannabis Science plans to enhance and enlarge certain dispensaries, and each site will be converted into the company brand.

Cannabis Science Inc (OTCMKTS:CBIS) reported that its expansions strategies are well underway as it has finalized deals to acquire and officially begin the preliminary “PRE ICO” Medical Marijuana dispensary in Los Angeles.

The details

Raymond C. Dabney, the CEO and President of Cannabis Science, reported that attaining this preliminary PRE ICO Dispensary in L.A. is a remarkable step for company as it paves the way to advance their planned expansion in the respective area and ultimately California statewide. This is a prime instance of their aggressive and resilient deals to buy numerous pharmacies across the Los Angeles segment. Finalizing this deal is just the initial step of several that Cannabis Science will be implementing to establish a countrywide presence.

Dabney added that as they buy these dispensaries their preliminary measure for some of them is to enhance, convert and enlarge each site into the company’s Brand, with Grand Openings demonstrating Cannabis Science offerings and quality Cannabinoid accessories and products for the doctors, patients and the consuming public.

Each site will permit for easier access and an improved selection of offerings for the customers. Products will range from extracts, sprays, pills, oils, creams, balms, patches, tinctures, edibles, and even merchandise. Not all offerings in the dispensary will be only from Cannabis Science, as they will be showcasing offerings from other reputable, regulated brands.

The company has been working assiduously toward introducing this very vital phase of growth. Cannabis Science is looking to start a number of sites throughout California in stage one via acquisition or associating with existing approved PRE ICO dispensary sites, and the complete build-out of new locations. Each site will be selectively chosen, allowing for company to establish effective and successful dispensaries. This is one of several intended vertical integration plans well underway at company.

In the last trading session, the stock price of Cannabis Science jumped more than 4% to close the day at $0.0551.